Iwao Ojima

25.7k total citations · 2 hit papers
455 papers, 19.3k citations indexed

About

Iwao Ojima is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Iwao Ojima has authored 455 papers receiving a total of 19.3k indexed citations (citations by other indexed papers that have themselves been cited), including 255 papers in Organic Chemistry, 154 papers in Molecular Biology and 136 papers in Oncology. Recurrent topics in Iwao Ojima's work include Cancer Treatment and Pharmacology (103 papers), Synthetic Organic Chemistry Methods (69 papers) and Asymmetric Hydrogenation and Catalysis (62 papers). Iwao Ojima is often cited by papers focused on Cancer Treatment and Pharmacology (103 papers), Synthetic Organic Chemistry Methods (69 papers) and Asymmetric Hydrogenation and Catalysis (62 papers). Iwao Ojima collaborates with scholars based in United States, Japan and Czechia. Iwao Ojima's co-authors include Tetsuo Kogure, Robert J. Donovan, Yasuyoshi Nagai, Takamasa Fuchikami, Maria Tzamarioudaki, Zhao‐Yang Li, Shin‐ichi Inaba, Songnian Lin, Ralph J. Bernacki and Francette Delaloge and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Iwao Ojima

447 papers receiving 18.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fluorine in Medicinal Chemistry and Chemical Biology

2009 1.6k citations Iwao Ojima profile →
Transition Metal-Catalyzed Carbocyclizations in Organic Synthesis

1996 744 citations Iwao Ojima et al. profile →

Peers

Countries citing papers authored by Iwao Ojima

Since Specialization

Citations

This map shows the geographic impact of Iwao Ojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iwao Ojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iwao Ojima more than expected).

Fields of papers citing papers by Iwao Ojima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iwao Ojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iwao Ojima. The network helps show where Iwao Ojima may publish in the future.

Co-authorship network of co-authors of Iwao Ojima

This figure shows the co-authorship network connecting the top 25 collaborators of Iwao Ojima. A scholar is included among the top collaborators of Iwao Ojima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iwao Ojima. Iwao Ojima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Astrocytic FABP5 mediates retrograde endocannabinoid transport at central synapses 2025 ·iScience ·(unknown), (unknown), Keith M. Studholme, (unknown), Sherrye T. Glaser, Roh‐Yu Shen, Iwao Ojima, Martin Kaczocha, Samir Haj‐Dahmane	2
2	Truxillic acid monoamides as fatty acid binding protein 5 inhibitors 2023 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Liqun Wang, Iwao Ojima, Martin Kaczocha	3
3	FABP5 Inhibition against PTEN-Mutant Therapy Resistant Prostate Cancer 2023 ·Cancers ·(unknown), Grinu Mathew, (unknown), (unknown), (unknown), Hehe Wang, Aashna Jhaveri, Jude Kendall, Hilary Cox, (unknown), Gissou Azabdaftari, Robert C. Rizzo, Sarah D. Diermeier, Iwao Ojima, Agnieszka B. Bialkowska, Martin Kaczocha, Lloyd C. Trotman	4
4	Fatty acid binding protein 5 inhibition attenuates pronociceptive cytokine/chemokine expression and suppresses osteoarthritis pain: A comparative human and rat study 2023 ·Osteoarthritis and Cartilage ·(unknown), (unknown), (unknown), Keith M. Studholme, (unknown), (unknown), (unknown), (unknown), (unknown), Ayesha Khan, (unknown), Zeyu Huang, (unknown), Shao‐Jun Tang, Hehe Wang, Iwao Ojima, (unknown), David E. Komatsu, Martin Kaczocha	7
5	Strategies for the drug discovery and development of taxane anticancer therapeutics 2022 ·Expert Opinion on Drug Discovery ·Changwei Wang, Angelo Aguilar, Iwao Ojima	15
6	Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids 2021 ·Bioorganic Chemistry ·Changwei Wang, (unknown), Yi Sun, (unknown), (unknown), Iwao Ojima	8
7	Novel T9 loop conformation of filamenting temperature-sensitive mutant Z from Mycobacterium tuberculosis 2019 ·Acta Crystallographica Section F Structural Biology Communications ·(unknown), Jean Jakoncic, (unknown), Divya Awasthi, Iwao Ojima	0
8	Contribution of diacylglycerol lipase β to pain after surgery 2018 ·Journal of Pain Research ·(unknown), Yong Lu, (unknown), Xiaoxue Peng, Diane Bogdan, Michelino Puopolo, David E. Komatsu, Simon Tong, Iwao Ojima, Mario J. Rebecchi, Martin Kaczocha	9
9	Fatty acid–binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation 2018 ·Journal of Biological Chemistry ·Diane Bogdan, (unknown), (unknown), Sang‐Hoon Park, Gregory Carbonetti, Keith M. Studholme, Marı́a Gómez, Yong Lu, Matthew W. Elmes, (unknown), Yan Su, Iwao Ojima, Michelino Puopolo, Martin Kaczocha	41
10	Nanoemulsion formulation of a novel taxoid DHA-SBT-1214 inhibits prostate cancer stem cell-induced tumor growth 2017 ·Cancer Letters ·Gulzar Ahmad, (unknown), Galina I. Botchkina, Iwao Ojima, James Egan, Mansoor M. Amiji	41
11	Drug resistance mechanisms and novel drug targets for tuberculosis therapy 2016 ·Journal of genetics and genomics ·Md. Mahmudul Islam, H. M. Adnan Hameed, (unknown), Chiranjibi Chhotaray, Changwei Wang, Yaoju Tan, Jianxiong Liu, Xinjie Li, Shouyong Tan, Iwao Ojima, Wing Wai Yew, Eric L. Nuermberger, Gyanu Lamichhane, Tianyu Zhang	66
12	Inexpensive chemical method for preparation of enantiomerically pure phenylalanine 2014 ·Amino Acids ·Hiroki Moriwaki, (unknown), Hengguang Li, Iwao Ojima, Ryosuke Takeda, José Luis Aceña, Vadim A. Soloshonok	13
13	Synthesis of Chiral Biphenol‐Based Diphosphonite Ligands and Their Application in Palladium‐Catalyzed Intermolecular Asymmetric Allylic Amination Reactions 2010 ·Chemistry - An Asian Journal ·Ce Shi, Chih‐Wei Chien, Iwao Ojima	8
14	Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells 2005 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Marie Ehrlichová, Radka Václavíková, Iwao Ojima, Antonella Pepe, Larisa Kuznetsova, Jin Chen, Jaroslav Truksa, Jan Kovář, Ivan Gut	36
15	Effects of Novel Taxanes SB-T-1213 and IDN5109 on Tubulin Polymerization and Mitosis 2002 ·Chemistry & Biology ·Mary Ann Jordan, Iwao Ojima, (unknown), Mariagrazia Distefano, Leslie Wilson, Giovanni Scambia, Cristiano Ferlini	29
16	Effects of Orally Active Taxanes on P-Glycoprotein Modulation and Colon and Breast Carcinoma Drug Resistance 2001 ·JNCI Journal of the National Cancer Institute ·(unknown), Iwao Ojima, Jean Veith, Paula Pera, (unknown), Fernando Cabral, A. Sharma, Peter M. Kanter, William R. Greco, Ralph J. Bernacki	74
17	Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site††This work was presented in part at the Association for Research in Vision and Ophthalmology annual meetings May 1999 and May 2000, Fort Lauderdale, FL, USA and at the Schepens Eye Research Institute's 50th Anniversary Symposium, October 2000.‡‡The nucleotide sequences reported in this paper have been submitted to the GenBankTM with accession numbers AF141347, AF141348, AF141349, AF141923, and AF147880. 2001 ·Bioorganic & Medicinal Chemistry ·Donald V. Crabtree, Iwao Ojima, Xudong Geng, Alice J. Adler	39
18	The efficacy of physiological cost index (PCI) measurement of a subject walking with an Intelligent Prosthesis 1999 ·Prosthetics and Orthotics International ·Takaaki Chin, (unknown), (unknown), (unknown), Iwao Ojima, Hiroko Oyabu, Yuji Nagakura, Hiroshi Otsuka, A. Nakagawa	36
19	New taxanes as highly efficient reversal agents for multi-drug resistance in cancer cells 1998 ·Bioorganic & Medicinal Chemistry Letters ·Iwao Ojima, (unknown), Craig S. Takeuchi, Paula Pera, Ralph J. Bernacki	46
20	An Efficient Synthesis of $\alpha,\beta-enoyl-\eta^5-(C_5H_5)Fe(CO)(PPh_3)$ Complexes 1994 ·Bulletin of the Korean Chemical Society ·(unknown), Iwao Ojima	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact